open access

Ahead of Print
ORIGINAL ARTICLES
Published online: 2020-08-22
Submitted: 2020-06-08
Accepted: 2020-07-27
Get Citation

Comparison of local rosmarinic acid and topical dexpanthenol applications on wound healing in a rat experimental wound model

M. C. Küba, A. Türkoğlu, A. Oğuz, M. C. Tuncer, Ş. Kaya, Ö. Başol, H. Bilge, F. Tatlı
DOI: 10.5603/FM.a2020.0097
·
Pubmed: 32844390

open access

Ahead of Print
ORIGINAL ARTICLES
Published online: 2020-08-22
Submitted: 2020-06-08
Accepted: 2020-07-27

Abstract

We compared the effects of rosmarinic acid and dexpanthenol in a rat experimental wound model. Twenty-four Wistar albino rats weighing 200–250 g were randomly divided into 3 groups. After 2-cm full-thickness skin defects were created, the wounds were washed with sterile 0.9% NaCl solution. After washing, the control group was left untreated, the second group received 5% dexpanthenol cream, and the third group received 10% rosmarinic acid cream. Before excision, the skin was evaluated macroscopically by measuring the reduction in wound size; after excision, histological examination (epithelization, inflammation, fibrosis, granulation) was performed. Macroscopic comparison of the wound sizes showed that group 3 showed a statistically significant difference in wound size reduction compared to the other two groups. Histopathological examination showed that there was no statistically significant difference between the groups. We found that the rosmarinic acid group had greater wound size reduction than the other two groups. However, epithelialization was detected in fewer cases. We believe that rosmarinic acid can be used as a topical cream for wound healing, as it leads to significant reduction in wound size, resulting in fewer scars.

Abstract

We compared the effects of rosmarinic acid and dexpanthenol in a rat experimental wound model. Twenty-four Wistar albino rats weighing 200–250 g were randomly divided into 3 groups. After 2-cm full-thickness skin defects were created, the wounds were washed with sterile 0.9% NaCl solution. After washing, the control group was left untreated, the second group received 5% dexpanthenol cream, and the third group received 10% rosmarinic acid cream. Before excision, the skin was evaluated macroscopically by measuring the reduction in wound size; after excision, histological examination (epithelization, inflammation, fibrosis, granulation) was performed. Macroscopic comparison of the wound sizes showed that group 3 showed a statistically significant difference in wound size reduction compared to the other two groups. Histopathological examination showed that there was no statistically significant difference between the groups. We found that the rosmarinic acid group had greater wound size reduction than the other two groups. However, epithelialization was detected in fewer cases. We believe that rosmarinic acid can be used as a topical cream for wound healing, as it leads to significant reduction in wound size, resulting in fewer scars.

Get Citation

Keywords

Wound healing, rosmarinic acid, dexpanthenol, rat

About this article
Title

Comparison of local rosmarinic acid and topical dexpanthenol applications on wound healing in a rat experimental wound model

Journal

Folia Morphologica

Issue

Ahead of Print

Published online

2020-08-22

DOI

10.5603/FM.a2020.0097

Pubmed

32844390

Keywords

Wound healing
rosmarinic acid
dexpanthenol
rat

Authors

M. C. Küba
A. Türkoğlu
A. Oğuz
M. C. Tuncer
Ş. Kaya
Ö. Başol
H. Bilge
F. Tatlı

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By  "Via Medica sp. z o.o." sp.k., Świętokrzyska 73, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl